Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma

被引:97
作者
Chen, CC
Yang, SY
Liu, CJ
Lin, CL
Liaw, YF
Lin, SM
Lee, SD
Chen, PJ
Chen, CJ
Yu, MW
机构
[1] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 100, Taiwan
[2] Chung Shan Med Univ Hosp, Dept Family Med, Taichung, Taiwan
[3] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan
[4] Taipei Municipal Jen Ai Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan
[5] Chang Gung Mem Hosp, Liver Res Unit, Taoyuan, Taiwan
[6] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[7] Natl Yang Ming Univ, Dept Med, Vet Gen Hosp, Taipei 112, Taiwan
[8] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
关键词
cytokine; DNA repair; hepatitis B; hepatocellular carcinoma;
D O I
10.1093/ije/dyi191
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Hepatitis B virus (HBV) induces hepatocellular carcinoma (HCC) mainly by causing chronic necroinflammatory hepatic disease. We investigated the mechanisms underlying the inflammatory hepatocarcinogenesis by examining whether genetic variations in cytokines, antioxidant enzymes, and DNA repair genes affect the HCC risk. Methods We analyzed 10 polymorphisms in the genes for interleukin-1 beta (IL-1B), interleukin-1-receptor antagonist (IL-1RN), tumor necrosis factor-alpha (TNF-A), glutathione S-transferase, XRCC1, hMLH1, and XPD in 577 HBV carriers with HCC and 389 HBV carrier controls. Results Overall, only the hMLH1-93(*)A allele significantly increased HCC risk. We identified polymorphism combinations associated with HCC. In the presence of the IL-1RN(*)2 allele, adjusted odds ratios (ORs) for HCC associated with C/C, T/C, and T/T genotypes of the IL-1B-31 polymorphism were 1.00, 2.93 [95% confidence interval (95% CI) 1.07-8.07], and 5.76 (95% CI 1.79-18.53), respectively. There was a dose-dependent association between the number of putative high-risk genotypes in the IL-1B, TNF-A, hMLH1, and XRCC1 genes and HCC. The adjusted OR for HBV carriers with >= 3 putative high-risk genotypes was 9.29 (95% CI 2.90-29.75) compared with those with none or only one of the high-risk genotypes. These associations were not observed among HBV carriers without the IL-1RN(*)2 allele. Smoking modified the combined effect of multiple loci in the IL-1RN, IL-1B, TNF-A, hMLH1, and XRCC1 genes; a high-risk multilocus genotype only significantly increased the risk in smokers (adjusted OR 4.84; 95% CI 1.69-13.92). Conclusions Genetic variations in cytokine and DNA repair genes contribute to susceptibility to HBV-related HCC. Smoking increased such genetic susceptibility.
引用
收藏
页码:1310 / 1318
页数:9
相关论文
共 40 条
[1]   Hepatitis B virus infection and hepatocellular carcinoma: Molecular genetics and clinical perspectives [J].
Chen, PJ ;
Chen, DS .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :253-262
[2]   Oxidative DNA damage: mechanisms, mutation, and disease [J].
Cooke, MS ;
Evans, MD ;
Dizdaroglu, M ;
Lunec, J .
FASEB JOURNAL, 2003, 17 (10) :1195-1214
[3]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[4]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[5]   Interleukin-1 polymorphisms associated with increased risk of gastric cancer [J].
El-Omar, EM ;
Carrington, M ;
Chow, WH ;
McColl, KEL ;
Bream, JH ;
Young, HA ;
Herrera, J ;
Lissowska, J ;
Yuan, CC ;
Rothman, N ;
Lanyon, G ;
Martin, M ;
Fraumeni, JF ;
Rabkin, CS .
NATURE, 2000, 404 (6776) :398-402
[6]  
Figueiredo C, 2002, J NATL CANCER I, V94, P1680, DOI 10.1093/jnci/94.22.1680
[7]  
Fleisher AS, 2000, CANCER RES, V60, P4864
[8]   Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan [J].
Furuta, T ;
El-Omar, EM ;
Xiao, F ;
Shirai, N ;
Takashima, M ;
Sugimurra, H .
GASTROENTEROLOGY, 2002, 123 (01) :92-105
[9]  
Gasche C, 2001, CANCER RES, V61, P7444
[10]   EXTENSIVE OXIDATIVE DNA-DAMAGE IN HEPATOCYTES OF TRANSGENIC MICE WITH CHRONIC ACTIVE HEPATITIS DESTINED TO DEVELOP HEPATOCELLULAR-CARCINOMA [J].
HAGEN, TM ;
HUANG, S ;
CURNUTTE, J ;
FOWLER, P ;
MARTINEZ, V ;
WEHR, CM ;
AMES, BN ;
CHISARI, FV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12808-12812